Vault-13

Eversept Partners, LP

NEW YORK, NY · CIK 1697013 · 13F filing filed 2025-05-15

SEC-registered investment adviser since 2017 · limited partnership

As an employer

Where they work

people there (dot area)number not reportedmain officeHover or tap a dot. Australian and UK companies are placed at their business or registered address, with their staff across the whole country.

Offices

From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.

CityCountryPeople
New York, NY (main office)United States United Statesabout 4
San Francisco, CAUnited States United States1

Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.

$883.7m reported value -8.8% vs Q4 2024
55positions
58.8%in top 10
12 new 22 added 20 reduced 19 sold out vs Q4 2024

Options: 0 call positions (— notional), 2 put positions ($101.0m notional) – listed below, not included above.

Holdings, Q1 2025

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 NATERA INC COM NTRA NTRA 893,721 $126.4m14.30% 14.30% AddedShares held: Q2 2024 1.2m, Q3 2024 870.2k, Q4 2024 876.8k, Q1 2025 893.7k +17.0k +16,955 1.9%
2 GSK PLC SPONSORED ADR GSK GSK 2,623,246 $101.6m11.50% 11.50% ReducedShares held: Q2 2024 3.5m, Q3 2024 4.1m, Q4 2024 3.7m, Q1 2025 2.6m -1.0m -1,038,522 -28.4%
3 HCA HEALTHCARE INC COM HCA HCA 152,502 $52.7m5.96% 5.96% ReducedShares held: Q2 2024 135.5k, Q3 2024 129.1k, Q4 2024 175.8k, Q1 2025 152.5k -23.3k -23,306 -13.3%
4 SYNDAX PHARMACEUTICALS INC COM SNDX SNDX 4,212,270 $51.7m5.86% 5.86% AddedShares held: Q2 2024 3.6m, Q3 2024 4.1m, Q4 2024 343.4k, Q1 2025 4.2m +3.9m +3,868,870 1126.6%
5 VERA THERAPEUTICS INC CL A VERA VERA 1,898,804 $45.6m5.16% 5.16% AddedShares held: Q2 2024 2.0m, Q3 2024 2.1m, Q4 2024 1.6m, Q1 2025 1.9m +298.8k +298,789 18.7%
6 REVVITY INC COM RVTY RVTY 299,087 $31.6m3.58% 3.58% ReducedShares held: Q2 2024 451.6k, Q3 2024 469.7k, Q4 2024 392.5k, Q1 2025 299.1k -93.4k -93,431 -23.8%
7 HEALTHEQUITY INC COM HQY HQY 351,976 $31.1m3.52% 3.52% ReducedShares held: Q2 2024 413.5k, Q3 2024 319.1k, Q4 2024 386.7k, Q1 2025 352.0k -34.7k -34,721 -9.0%
8 INSPIRE MED SYS INC COM INSP INSP 186,425 $29.7m3.36% 3.36% ReducedShares held: Q2 2024 533.0k, Q3 2024 276.3k, Q4 2024 294.3k, Q1 2025 186.4k -107.9k -107,877 -36.7%
9 PROTAGONIST THERAPEUTICS INC COM PTGX PTGX 547,116 $26.5m2.99% 2.99% ReducedShares held: Q2 2024 505.8k, Q3 2024 445.2k, Q4 2024 678.8k, Q1 2025 547.1k -131.7k -131,671 -19.4%
10 COMMUNITY HEALTH SYS INC NEW COM CYH CYH 8,458,020 $22.8m2.58% 2.58% AddedShares held: Q2 2024 8.0m, Q3 2024 8.8m, Q4 2024 2.8m, Q1 2025 8.5m +5.6m +5,631,020 199.2%
11 ZIMVIE INC COM ZIMV ZIMV 2,079,380 $22.5m2.54% 2.54% AddedShares held: Q2 2024 767.7k, Q3 2024 2.1m, Q4 2024 2.1m, Q1 2025 2.1m +8.6k +8,600 0.4%
12 TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS SPONSORED ADS 1,410,765 $21.7m2.45% 2.45% ReducedShares held: Q2 2024 4.7m, Q3 2024 3.2m, Q4 2024 2.2m, Q1 2025 1.4m -831.4k -831,360 -37.1%
13 VAXCYTE INC COM PCVX PCVX 557,070 $21.0m2.38% 2.38% AddedShares held: Q2 2024 96.1k, Q3 2024 0, Q4 2024 127.6k, Q1 2025 557.1k +429.5k +429,482 336.6%
14 BRUKER CORP COM BRKR BRKR 499,207 $20.8m2.36% 2.36% AddedShares held: Q2 2024 0, Q3 2024 0, Q4 2024 234.9k, Q1 2025 499.2k +264.3k +264,273 112.5%
15 CENTENE CORP DEL COM CNC CNC 340,339 $20.7m2.34% 2.34% AddedShares held: Q2 2024 115.8k, Q3 2024 135.0k, Q4 2024 188.5k, Q1 2025 340.3k +151.8k +151,846 80.6%
16 VIRIDIAN THERAPEUTICS INC COM VRDN VRDN 1,377,674 $18.6m2.10% 2.10% AddedShares held: Q2 2024 567.5k, Q3 2024 691.2k, Q4 2024 780.0k, Q1 2025 1.4m +597.7k +597,676 76.6%
17 NEUROCRINE BIOSCIENCES INC COM NBIX NBIX 167,243 $18.5m2.09% 2.09% NewShares held: Q2 2024 0, Q3 2024 0, Q4 2024 0, Q1 2025 167.2k
18 UNITED THERAPEUTICS CORP DEL COM UTHR UTHR 57,489 $17.7m2.01% 2.01% AddedShares held: Q2 2024 235.4k, Q3 2024 130.9k, Q4 2024 43.7k, Q1 2025 57.5k +13.8k +13,786 31.5%
19 BIO-TECHNE CORP COM TECH TECH 280,117 $16.4m1.86% 1.86% ReducedShares held: Q2 2024 543.0k, Q3 2024 663.6k, Q4 2024 299.3k, Q1 2025 280.1k -19.2k -19,193 -6.4%
20 BIOCRYST PHARMACEUTICALS INC COM BCRX BCRX 2,172,436 $16.3m1.84% 1.84% AddedShares held: Q2 2024 1.2m, Q3 2024 535.4k, Q4 2024 2.0m, Q1 2025 2.2m +192.1k +192,124 9.7%
21 GLAUKOS CORP COM GKOS GKOS 158,957 $15.6m1.77% 1.77% NewShares held: Q2 2024 0, Q3 2024 0, Q4 2024 0, Q1 2025 159.0k
22 IONIS PHARMACEUTICALS INC COM IONS IONS 517,021 $15.6m1.77% 1.77% AddedShares held: Q2 2024 456.9k, Q3 2024 471.4k, Q4 2024 215.0k, Q1 2025 517.0k +302.1k +302,069 140.5%
23 TRAVERE THERAPEUTICS INC COM TVTX TVTX 816,254 $14.6m1.66% 1.66% AddedShares held: Q2 2024 1.1m, Q3 2024 869.9k, Q4 2024 490.3k, Q1 2025 816.3k +326.0k +325,958 66.5%
24 GLOBUS MED INC CL A GMED GMED 192,893 $14.1m1.60% 1.60% NewShares held: Q2 2024 0, Q3 2024 0, Q4 2024 0, Q1 2025 192.9k
25 CELLDEX THERAPEUTICS INC NEW COM NEW CLDX CLDX 696,499 $12.6m1.43% 1.43% ReducedShares held: Q2 2024 633.0k, Q3 2024 564.9k, Q4 2024 719.8k, Q1 2025 696.5k -23.3k -23,337 -3.2%
26 INVESCO QQQ TR UNIT SER 1 QQQ QQQ 24,003 $11.3m1.27% 1.27% NewShares held: Q2 2024 0, Q3 2024 0, Q4 2024 0, Q1 2025 24.0k
27 ALIGN TECHNOLOGY INC COM ALGN ALGN 49,277 $7.8m0.89% 0.89% NewShares held: Q2 2024 0, Q3 2024 0, Q4 2024 0, Q1 2025 49.3k
28 TELEFLEX INCORPORATED COM TFX TFX 56,630 $7.8m0.89% 0.89% ReducedShares held: Q2 2024 0, Q3 2024 0, Q4 2024 61.7k, Q1 2025 56.6k -5.1k -5,106 -8.3%
29 MOLINA HEALTHCARE INC COM MOH MOH 23,735 $7.8m0.88% 0.88% NewShares held: Q2 2024 18.3k, Q3 2024 10.6k, Q4 2024 0, Q1 2025 23.7k
30 HUMANA INC COM HUM HUM 27,970 $7.4m0.84% 0.84% AddedShares held: Q2 2024 38.0k, Q3 2024 33.9k, Q4 2024 22.7k, Q1 2025 28.0k +5.3k +5,288 23.3%
31 ELEVANCE HEALTH INC COM ELV ELV 15,698 $6.8m0.77% 0.77% ReducedShares held: Q2 2024 14.7k, Q3 2024 19.5k, Q4 2024 29.2k, Q1 2025 15.7k -13.5k -13,480 -46.2%
32 NEWAMSTERDAM PHARMA COMPANY ORDINARY SHARES NAMS NAMS 280,951 $5.8m0.65% 0.65% AddedShares held: Q2 2024 329.9k, Q3 2024 307.4k, Q4 2024 275.4k, Q1 2025 281.0k +5.6k +5,589 2.0%
33 GOSSAMER BIO INC COM GOSS GOSS 3,896,841 $4.3m0.49% 0.49% ReducedShares held: Q2 2024 5.5m, Q3 2024 5.0m, Q4 2024 5.0m, Q1 2025 3.9m -1.1m -1,081,617 -21.7%
34 ZENAS BIOPHARMA INC COM ZBIO ZBIO 445,588 $3.5m0.40% 0.40% AddedShares held: Q2 2024 0, Q3 2024 190.5k, Q4 2024 172.1k, Q1 2025 445.6k +273.5k +273,485 158.9%
35 MANNKIND CORP COM NEW MNKD MNKD 697,710 $3.5m0.40% 0.40% ReducedShares held: Q2 2024 2.3m, Q3 2024 2.0m, Q4 2024 911.0k, Q1 2025 697.7k -213.3k -213,315 -23.4%
36 MERUS N V COM MRUS MRUS 70,329 $3.0m0.33% 0.33% AddedShares held: Q2 2024 66.5k, Q3 2024 68.3k, Q4 2024 68.3k, Q1 2025 70.3k +2.1k +2,071 3.0%
37 REPLIGEN CORP COM RGEN RGEN 18,452 $2.3m0.27% 0.27% ReducedShares held: Q2 2024 194.3k, Q3 2024 163.6k, Q4 2024 54.1k, Q1 2025 18.5k -35.6k -35,614 -65.9%
38 NOVAVAX INC COM NEW NVAX NVAX 365,523 $2.3m0.27% 0.27% NewShares held: Q2 2024 0, Q3 2024 0, Q4 2024 0, Q1 2025 365.5k
39 LIQUIDIA CORPORATION COM NEW LQDA LQDA 150,480 $2.2m0.25% 0.25% ReducedShares held: Q2 2024 373.6k, Q3 2024 137.9k, Q4 2024 571.3k, Q1 2025 150.5k -420.8k -420,825 -73.7%
40 FORTREA HLDGS INC COMMON STOCK FTRE FTRE 293,275 $2.2m0.25% 0.25% ReducedShares held: Q2 2024 0, Q3 2024 458.0k, Q4 2024 401.7k, Q1 2025 293.3k -108.5k -108,458 -27.0%
41 89BIO INC COM ETNB ETNB 303,731 $2.2m0.25% 0.25% NewShares held: Q2 2024 0, Q3 2024 0, Q4 2024 0, Q1 2025 303.7k
42 MARAVAI LIFESCIENCES HLDGS I COM CL A MRVI MRVI 942,454 $2.1m0.24% 0.24% NewShares held: Q2 2024 0, Q3 2024 337.0k, Q4 2024 0, Q1 2025 942.5k
43 AVANTOR INC COM AVTR AVTR 122,823 $2.0m0.23% 0.23% ReducedShares held: Q2 2024 125.4k, Q3 2024 168.4k, Q4 2024 168.4k, Q1 2025 122.8k -45.5k -45,546 -27.1%
44 ICON PLC SHS ICLR ICLR 10,840 $1.9m0.21% 0.21% ReducedShares held: Q2 2024 12.6k, Q3 2024 13.7k, Q4 2024 19.3k, Q1 2025 10.8k -8.4k -8,412 -43.7%
45 INFLARX NV COM IFRX IFRX 1,675,978 $1.7m0.19% 0.19% AddedShares held: Q2 2024 1.6m, Q3 2024 1.6m, Q4 2024 492.5k, Q1 2025 1.7m +1.2m +1,183,526 240.3%
46 AMARIN CORP PLC SPONS ADR NEW SPONS ADR NEW 3,399,204 $1.5m0.17% 0.17% AddedShares held: Q2 2024 4.3m, Q3 2024 3.3m, Q4 2024 1.5m, Q1 2025 3.4m +1.9m +1,882,612 124.1%
47 SUTRO BIOPHARMA INC COM COM 2,292,261 $1.5m0.17% 0.17% AddedShares held: Q2 2024 1.7m, Q3 2024 1.8m, Q4 2024 694.4k, Q1 2025 2.3m +1.6m +1,597,853 230.1%
48 ITEOS THERAPEUTICS INC COM ITOS ITOS 220,196 $1.3m0.15% 0.15% UnchangedShares held: Q2 2024 0, Q3 2024 0, Q4 2024 220.2k, Q1 2025 220.2k
49 KARYOPHARM THERAPEUTICS INC COM NEW KPTI KPTI 257,154 $961.8k0.11% 0.11% NewShares held: Q2 2024 0, Q3 2024 0, Q4 2024 0, Q1 2025 257.2k
50 XOMA ROYALTY CORPORATION COM NEW XOMA XOMA 45,017 $897.2k0.10% 0.10% ReducedShares held: Q2 2024 91.9k, Q3 2024 94.3k, Q4 2024 95.4k, Q1 2025 45.0k -50.4k -50,400 -52.8%
51 PUMA BIOTECHNOLOGY INC COM PBYI PBYI 275,788 $816.3k0.09% 0.09% ReducedShares held: Q2 2024 1.3m, Q3 2024 1.3m, Q4 2024 996.1k, Q1 2025 275.8k -720.3k -720,314 -72.3%
52 ALECTOR INC COM ALEC ALEC 617,418 $759.4k0.09% 0.09% AddedShares held: Q2 2024 541.7k, Q3 2024 332.8k, Q4 2024 200.1k, Q1 2025 617.4k +417.3k +417,323 208.6%
53 EHEALTH INC COM EHTH EHTH 89,220 $596.0k0.07% 0.07% NewShares held: Q2 2024 0, Q3 2024 0, Q4 2024 0, Q1 2025 89.2k
54 AUTOLUS THERAPEUTICS PLC SPON ADS AUTL AUTL 343,947 $533.1k0.06% 0.06% AddedShares held: Q2 2024 610.9k, Q3 2024 406.6k, Q4 2024 98.9k, Q1 2025 343.9k +245.1k +245,052 247.8%
55 AC IMMUNE SA SHS ACIU ACIU 100,752 $188.4k0.02% 0.02% NewShares held: Q2 2024 99.3k, Q3 2024 99.3k, Q4 2024 0, Q1 2025 100.8k

Sold out since Q4 2024

SecurityTickerShares held beforeValue then
VIATRIS INC VTRS VTRS 1,272,102 $15.8m1.3m shares
EDWARDS LIFESCIENCES CORP EW EW 170,678 $12.6m170.7k shares
DEXCOM INC DXCM DXCM 148,688 $11.6m148.7k shares
GUARDANT HEALTH INC GH GH 276,036 $8.4m276.0k shares
ASTRAZENECA PLC 102,661 $6.7m102.7k shares
MEDPACE HLDGS INC MEDP MEDP 19,049 $6.3m19.0k shares
XENON PHARMACEUTICALS INC XENE XENE 155,540 $6.1m155.5k shares
HENRY SCHEIN INC HSIC HSIC 80,303 $5.6m80.3k shares
DANAHER CORPORATION DHR DHR 22,209 $5.1m22.2k shares
PATTERSON COS INC PDCO PDCO 146,051 $4.5m146.1k shares
EVOLUS INC EOLS EOLS 383,045 $4.2m383.0k shares
SUPERNUS PHARMACEUTICALS INC SUPN SUPN 105,581 $3.8m105.6k shares
2SEVENTY BIO INC TSVT TSVT 1,003,678 $3.0m1.0m shares
MEREO BIOPHARMA GROUP PLC MREO MREO 777,890 $2.7m777.9k shares
ZAI LAB LTD ZLAB ZLAB 102,930 $2.7m102.9k shares
ARCUTIS BIOTHERAPEUTICS INC ARQT ARQT 191,158 $2.7m191.2k shares
DENTSPLY SIRONA INC XRAY XRAY 139,656 $2.7m139.7k shares
KARYOPHARM THERAPEUTICS INC 2,088,757 $1.4m2.1m shares
ABSCI CORPORATION ABSI ABSI 199,464 $522.6k199.5k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
INVESCO QQQ TR QQQ · Put QQQPut 123,600 $58.0m123.6k shares Reduced
SPDR S&P 500 ETF TR SPY · Put SPYPut 76,900 $43.0m76.9k shares Added

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
COMMUNITY HEALTH SYS INC NEW CYH · 13G · filed 2026-02-17 CYH 5.7%≈ $26.5m +1.3 pts 13G 2026-02-17